Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
1,685
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Donor cell leukemia/myelodysplastic syndrome after allogeneic stem cell transplantation: a rare phenomenon with more challenges for hematologists

Suping Zhanga The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Li Lia The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Weijie Caoa The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Yingmei Lia The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Zhongxing Jianga The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaView further author information
,
Jifeng Yua The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China;b Academy of Medical and Pharmaceutical Sciences of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-1217-4385View further author information
ORCID Icon &
Dingming Wana The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 648-651 | Published online: 03 Sep 2021

References

  • Hertenstein B, Hambach L, Bacigalupo A, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation – a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2005;90:969–975.
  • Hayes C, Petersen B, Malone A. Donor cell myeloid sarcoma in an umbilical cord transplant patient: A case report and a review of the literature. Case Rep Hematol 2015;2015:186869.
  • Wiseman DH. Donor cell leukemia: a review. Biol Blood Marrow Transplant. 2011;17:771–789.
  • Flach J, Shumilov E, Wiedemann G, et al. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. Hematol Oncol. 2020;38(4):425–431.
  • Yu J, Li Y, Zhang D, et al. Clinical implications of recurrent gene mutations in acute myeloid leukemia. Exp Hematol Oncol. 2020;9:4.
  • Winer ES. Secondary acute myeloid leukemia: a primary challenge of diagnosis and treatment. Hematol Oncol Clin North Am. 2020;34:449–463.
  • Taniguchi R, Muramatsu H, Okuno Y, et al. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement. Pediatr Blood Cancer. 2018;65(2).
  • Bouvier A, Ribourtout B, Francois S, et al. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2018;101:570–574.
  • Suárez-González J, Martínez-Laperche C, Martínez N, et al. Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis. Leukemia. 2018;32:1822–1826.
  • Suarez-Gonzalez J, Martinez-Laperche C, Kwon M, et al. Donor cell-derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review. Biol Blood Marrow Transplant. 2018;24:1505–1513.
  • Gabay T S, Chapal-Ilani N, Moskovitz Y, et al. Donor cell leukemia: reappearance of gene mutations in donor cells - more than an incidental phenomenon? Haematologica. 2020;105(12):2861–2863.
  • Yu J, Jiang PYZ, Sun H, et al. Advances in targeted therapy for acute myeloid leukemia. Biomark Res. 2020;8:17.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.